Fortune Minerals Limited (FTMDF: OTCQX International) |

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Fortune Minerals Limited (FTMDF: OTCQX International) | Fortune Minerals Provides Shareholder Update Fortune Minerals Provides Shareholder Update

Fortune Minerals Provides Shareholder Update

Canada NewsWire

First quarter 2013 results filed

Issued Capital: 121,276,976

LONDON, ON , May 6, 2013 /CNW/ - Fortune Minerals Limited (TSX: FT) (OTCQX: FTMDF) ("Fortune Minerals" or the "Company")  reports that its consolidated financial statements and management's discussion and analysis of financial condition and results of operations for the period ended March 31, 2013 have been filed and are available on SEDAR ( www.sedar.com ) or through the Company's web site ( www.fortuneminerals.com ).

Fortune has two advanced development assets: the Arctos Anthracite Project in northwest British Columbia ("BC"); and the NICO Gold-Cobalt-Bismuth-Copper Project in the Northwest Territories ("NT"), which will also include a proposed refinery to process concentrates to high value products. Both projects have been assessed in positive detailed feasibility studies, and their development risk mitigated from extensive work including test mining and pilot plant processing. Both projects are progressing through environmental assessments.

The following is reproduced from the Company's Annual Review and President's letter to shareholders forming part of the materials to be provided to shareholders in connection with the Company's annual meeting scheduled for June 25, 2013 :

The past two and a half years have seen a sustained bear market for the resource industry that has eroded share prices for many companies. We, however, remain committed to our view that the Earth's inventory of readily accessible mineral deposits is in decline and companies with high quality assets will benefit from the increasing demand for commodities when confidence returns to our sector in the capital markets.

Over the past two years, Fortune Minerals has carefully managed its cash resources while successfully advancing its Arctos and NICO projects through detailed feasibility studies and the environmental assessment process. The 2012 Front-End Engineering and Design study completed for NICO demonstrated a positive rate of return for the development with a significant increase to the mineral reserves to 33 million tonnes, including a 20% increase in the gold content to 1.1 million ounces. With a positive recommendation for approval received recently from the Mackenzie Valley Review Board, the NICO project will be ready for construction upon receipt of the final permits and requisite project financing. Similarly, the updated Arctos feasibility study indicates robust economics with increased run-of-mine coal reserves of 125 million tonnes within a much larger underexplored historical resource. Based on the revised project description, the Arctos project is actively conducting environmental work to support the EA process.

Concurrent with advancing the operational side of our two development assets, Fortune Minerals has been pursuing a project financing strategy based on forming joint ventures with strategic partners and building on the successful first stage partnership we have with POSCO for our Arctos project. The current state of the capital markets only reinforces our view that this is the correct approach. The Company has been working with Deloitte & Touche Corporate Finance Canada, our financial advisor, to leverage its significant global platform and build important relationships with potential partners, particularly in Asia . Fortune Minerals is advancing discussions with prospective partners and is committed to successfully completing the plan.

I am very proud of the team we have assembled over the years at Fortune Minerals. We continue to build our capacity with the addition of key people needed to properly execute our plan, including the appointment of Mike Romaniuk as Vice President of Operations and Chief Operating Officer. Mike's expertise, gained from more than two decades with Xstrata Nickel and Falconbridge , includes managing complex mining projects through the various stages of development and operations and makes him a timely addition to lead the development of our NICO and Arctos projects.

Fortune Minerals recognizes the importance of sustainable development that balances economic opportunity with environmental stewardship and the social license to operate. Significant effort is being made to engage with communities and regulators to mitigate potential impacts from our developments and benefit First Nations and stakeholders. The Company's efforts are recognized by the Canadian Council for Aboriginal Business through our participation in the Progressive Aboriginal Relations program at the Committed Level. This "PAR" program is the first and only corporate responsibility assurance program in the world with an emphasis on aboriginal relations.

Fortune Minerals has the assets, the people and the plan to transition through construction and realize our goal of becoming a diversified Canadian producer of metallurgical coal, gold and specialty metals to service a world economy that needs access to raw materials.

Robin E. Goad , President and CEO

About Fortune Minerals:
Fortune Minerals is a diversified resource company with several mineral deposits and a number of exploration projects, all located in Canada .  The Company is focused on the development of the Arctos Anthracite Project in British Columbia and the NICO gold-cobalt-bismuth-copper deposit in the Northwest Territories ("NT").  As part of the development of the NICO deposit, Fortune Minerals is developing the Saskatchewan Metals Processing Plant ("SMPP") in Saskatchewan to process NICO concentrates to high value metal products.  In addition, the Company owns the Sue-Dianne copper-silver-gold deposit and other exploration projects in the NT. Fortune Minerals is focused on outstanding performance and growth of shareholder value through assembly and development of high quality mineral resource projects.

The disclosure of scientific and technical information contained in this press release has been approved by Robin Goad, M.Sc., P.Geo., President and Chief Executive Officer of the Company, who is a "qualified person" under National Instrument 43-101.
This discussion contains certain forward-looking information. This forward-looking information includes, or may be based upon, estimates, forecasts, and statements as to management's expectations with respect to, among other things, the size and quality of the Company's mineral resources, progress in development of mineral properties,  securing of strategic investors for the Company's mineral projects, demand and market outlook for metals and coal and future metal and coal prices. Forward-looking information is based on the opinions and estimates of management at the date the information is given, and is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. These factors include the inherent risks involved in the exploration and development of mineral properties, uncertainties with respect to the receipt or timing of required permits and regulatory approvals, the uncertainties involved in interpreting drilling results and other geological data, fluctuating metal and coal prices, the possibility of project cost overruns or unanticipated costs and expenses, uncertainties with respect to the Company's ability to secure strategic investors, other uncertainties relating to the availability and costs of financing needed in the future, uncertainties related to metal recoveries and other factors. Readers are cautioned to not place undue reliance on forward-looking information because it is possible that predictions, forecasts, projections and other forms of forward-looking information will not be achieved by the Company. The forward-looking information contained herein is made as of the date hereof and the Company assumes no responsibility to update or revise it to reflect new events or circumstances, except as required by law.

SOURCE Fortune Minerals Limited

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 501

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 15

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 31

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 55

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

BioSyent Inc. to Announce Q3 Financial Results This Month

Updated Category News Views 189

BioSyent Inc. to Announce Q3 Financial Results BioSyent Inc., a prominent player in the specialty pharmaceutical industry, is preparing to release its financial results for the third quarter and year-to-date period. This important announcement is scheduled for November 20, prior to the market opening. The report will cover the company's performance for the three and nine...

Continue Reading
Dr. Ryan Egeland Joins Solventum as Chief Medical Officer

Updated Category News Views 381

Solventum Welcomes Dr. Ryan Egeland as New CMO Solventum, a pioneering healthcare company, recently announced the appointment of Dr. Ryan Egeland, MD, as their Chief Medical Officer. In this significant role, Dr. Egeland will lead the Global Medical and Clinical Affairs team, amplifying clinician and patient voices within the organization. Fostering Collaboration and...

Continue Reading
MiningToken Revolutionizes Cryptocurrency With AI Power

Updated Category News Views 186

Introducing MiningToken's Innovative AI Cloud Mining Service Bitcoin and Ethereum are experiencing remarkable market dynamics as Bitcoin persists in a bullish trend and Ethereum has gained notable ground recently. As global interest in cryptocurrencies grows, effective mining strategies are crucial for profitability. Amidst rising operational costs, many individuals seek...

Continue Reading
Saluda Medical's EVA™ Sensing Technology Approved in Europe

Updated Category News Views 111

Saluda Medical Achieves Regulatory Milestone with EVA™ Technology Saluda Medical, Inc. (ASX:SLD) has made significant strides in the medical device industry by achieving CE certification for its next-generation EVA™ Sensing Technology. This advancement not only marks a major endorsement in Europe but also is recognized in Australia. Following FDA approval in December...

Continue Reading
ReadPartner Inc. Unveils Revolutionary AI Tool to Combat Misinformation

Updated Category News Views 291

ReadPartner Inc. Launches AI Feature to Tackle Misinformation ReadPartner Inc., a leader in AI-driven media intelligence solutions, is excited to announce the upcoming launch of a groundbreaking digital security feature named ProfileScreen. This innovative tool aims to address the pressing issue of misinformation that plagues social media platforms. The ProfileScreen...

Continue Reading